Cargando…
A novel RNA sequencing‐based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and the second leading cause of cancer‐related deaths worldwide. Given that the rate of HCC recurrence 5 years after liver resection is as high as 70%, patient with HCC typically has a poor outcome. A biomarker or set of biomarke...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026871/ https://www.ncbi.nlm.nih.gov/pubmed/29719937 http://dx.doi.org/10.1002/1878-0261.12315 |